Pharma Industrial India - Professional magazine for pharma industry suppliers and lab technology

GSK's Jemperli Shows Durable Complete Responses in Rectal CancerGSK's Jemperli (dostarlimab) achieved durable complete responses in dMMR/MSI-H locally adva

GSK's Jemperli (dostarlimab) achieved durable complete responses in dMMR/MSI-H locally advanced rectal cancer, with potential to avoid chemotherapy, radiation, and surgery in some patients.

Clinical Trials | 14/07/2026 | By News Bureau

Emcure Takes Full Ownership of Gennova, Strengthens Focus on Biologics and Biosimilars

Market

Santhera Expands Agamree Distribution Partnership with Biomedica Across Five Additional Markets

Market

TolerogenixX Secures EU Orphan Drug Designation for MIC-Lx in Living-Donor Kidney Transplantation

Quality / GMP

Fischer Medical Ventures Strengthens AI Life Sciences Partnership with Nanyang Biologics

Digitalization

More news

Pharma Industrial Magazine

All magazines | Subscribe

Interviews

Advancing Biologics Manufacturing Through Innovation

Sachin Joshi, Managing Director and Co-Founder, PharmNXT

Sachin Joshi, Managing Director and Co-Founder, PharmNXT, discusses biologics supply chains, single-use technologies, localisation, and the future of biologics manufacturing, in an exclusive interview with Pharma In...

Reimagining Drug Discovery and Pharma Operations with AI

Greg Killian, SVP and Global Head-Life Sciences and Health Care Business, EPAM Systems

Organisations are increasingly leveraging Artificial Intelligence (AI), data, and digital engineering to drive innovation and operational excellence. Greg Killian, Senior Vice President (SVP) and Global Head–L...

Inspection Readiness Begins with a Culture of Quality

Arushi Jain, Director, Akums Drugs & Pharmaceuticals

Arushi Jain, Director, Akums Drugs & Pharmaceuticals, shares her insights with Pharma Industrial India on pharma inspection readiness, quality assurance, automation, data analytics, and digital transformation in...

All interviews

Articles

Pharma Needs Better Decisions, Not More Data

Pharma doesn’t lack data—it struggles with decisions. Fragmented systems and weak workflows slow outcomes, but Artificial Intelligence (AI) and better data curation can unlock real insights....

How Expanding Access to Chelation Therapy Is Reshaping Wilson Disease Management in India

India’s rare disease landscape is shifting from innovation to access, with improved availability of chelation therapies like Trientine highlighting how regulatory pathways, industry efforts and evolving clinic...

The Invisible Risk in Cleanrooms

Why must personnel apparel be taken seriously? Using Personal Protective Equipment (PPE) is one of the most important contamination control decisions in pharmaceutical manufacturing....

All articles